HeavenlyRx, a portfolio company of SOL Global Investments Corp SOLCF, has announced it's entering into a letter of intent to acquire Airganics. The value of the deal is $10 million.
The acquisition of Airganics will allow HeavenlyRx, which holds controlling interests in hemp/CBD and THC-free cannabinoid wellness space, to add three new brands.
Airganics is focused on developing high-performance wellness products, which has three brands in its portfolio: MOXE, an aromatherapy diffuser that will include a CBD line later this year; Nutriair, an inhalable nutrient delivery service; and ENVY HEMP, which includes tinctures, capsules, vapes, and energy shots.
All brands are focused to capture the CBD wellness space and already have distribution channels.
Related Links:
Discussing Sol Global's $30M Hemp Biomass Investment With CEO Brady Cobb
OrganiGram Announces Proprietary Technology For Cannabis-Infused Edibles
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
